COVID-CNS study underway - understanding the causes of neurological complications in Covid-19

Covid-19 is associated with a broad spectrum of acute neurological complications. The COVID-19 Clinical Neuroscience Study (COVID-CNS) is a UK-wide case-control study designed to understand why neurological complications occur in order to develop strategies to prevent and treat them.

The study will involve in-depth clinical, laboratory and imaging studies of 800 Covid-19 patients admitted to hospital with neurological complications compared to 500 control patients (hospitalised during the pandemic with and without Covid-19).

The study is led by the University of Liverpool and King's College London and funded by a £2.3M grant from UKRI and Department of Health and Social Care. Edinburgh is one of 13 participating centres and will be led locally by Dr David Breen (site lead), Dr Nadine Cossette (Recruitment lead, NHS Lothian), Professor Scott Semple (Imaging lead, Queen’s Medical Research Institute), Professor Andrew McIntosh and Professor Alan Carson (all Centre for Clinical Brain Sciences unless otherwise indicated).